HK1065844A1 - Cell migration assay - Google Patents
Cell migration assayInfo
- Publication number
- HK1065844A1 HK1065844A1 HK04108760A HK04108760A HK1065844A1 HK 1065844 A1 HK1065844 A1 HK 1065844A1 HK 04108760 A HK04108760 A HK 04108760A HK 04108760 A HK04108760 A HK 04108760A HK 1065844 A1 HK1065844 A1 HK 1065844A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cell migration
- migration assay
- discrimination
- kit
- directed
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Spectrometry And Color Measurement (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29668201P | 2001-06-07 | 2001-06-07 | |
| PCT/US2002/016325 WO2002101350A2 (en) | 2001-06-07 | 2002-05-22 | Cell migration assay |
| US10/154,399 US7282338B2 (en) | 2001-06-07 | 2002-05-22 | Cell migration assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1065844A1 true HK1065844A1 (en) | 2005-03-04 |
Family
ID=26851415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04108760A HK1065844A1 (en) | 2001-06-07 | 2004-11-08 | Cell migration assay |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7282338B2 (xx) |
| EP (2) | EP1417488B1 (xx) |
| JP (2) | JP4233092B2 (xx) |
| KR (2) | KR100598309B1 (xx) |
| AT (1) | ATE347695T1 (xx) |
| CA (1) | CA2449628C (xx) |
| DE (1) | DE60216606T2 (xx) |
| DK (1) | DK1417488T3 (xx) |
| ES (1) | ES2274041T3 (xx) |
| HK (1) | HK1065844A1 (xx) |
| WO (1) | WO2002101350A2 (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100598309B1 (ko) * | 2001-06-07 | 2006-07-10 | 케모센트릭스, 인크. | 세포 이동성 검사 |
| AU2003267088A1 (en) * | 2002-09-11 | 2004-04-30 | Medical College Of Georgia Research Institute, Inc. | Chemokine receptor antagonists as therapeutic agents |
| WO2004045526A2 (en) * | 2002-11-15 | 2004-06-03 | Morehouse School Of Medicine | Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| KR100874292B1 (ko) | 2002-11-18 | 2008-12-18 | 케모센트릭스 | 아릴 술폰아마이드 |
| CN1914313A (zh) * | 2004-02-13 | 2007-02-14 | 旭科技玻璃股份有限公司 | 胚胎干细胞用喂食细胞培育培养基及喂食细胞 |
| US7622583B2 (en) | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
| ATE503741T1 (de) | 2005-01-14 | 2011-04-15 | Chemocentryx Inc | Heteroarylsulfonamide und ccr2 |
| US8519135B2 (en) | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
| KR101433392B1 (ko) | 2006-07-14 | 2014-08-29 | 케모센트릭스, 인크. | 트리아졸릴 페닐 벤젠설폰아마이드 |
| AR061929A1 (es) * | 2006-07-18 | 2008-10-01 | Noxxon Pharma Ag | Acidos nucleicos de union al factor derivado de celulas estomales sdf-1 |
| KR101969689B1 (ko) | 2007-07-12 | 2019-04-16 | 케모센트릭스, 인크. | 염증의 치료를 위한 ｃｃｒ2 조절물질로서 융합된 헤테로아릴 피리딜과 페닐 벤젠술폰아마이드 |
| BRPI0815094B8 (pt) * | 2007-08-06 | 2023-04-18 | Noxxon Pharma Ag | Uso de uma molécula de ácido l-nucleico ligada a sdf-1 |
| CN103108641B (zh) | 2010-09-09 | 2016-01-13 | 诺松制药股份公司 | Sdf-1结合性核酸及其在癌症治疗中的用途 |
| EA029419B1 (ru) | 2010-11-19 | 2018-03-30 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Нейтрализующие антитела против ccl20 |
| CN104849377A (zh) * | 2015-01-29 | 2015-08-19 | 衢州市质量技术监督检测中心 | 一种气质法快速测定畜禽肉中β-兴奋剂的前处理方法 |
| KR20240130832A (ko) | 2016-11-23 | 2024-08-29 | 케모센트릭스, 인크. | 국소 분절 사구체경화증의 치료 방법 |
| JOP20190187A1 (ar) | 2017-02-03 | 2019-08-01 | Novartis Ag | مترافقات عقار جسم مضاد لـ ccr7 |
| EP3694504A4 (en) | 2017-10-11 | 2021-07-14 | ChemoCentryx, Inc. | TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH CRC2 ANTAGONISTS |
| US11995833B2 (en) | 2020-07-31 | 2024-05-28 | The Joan and Irwin Jacobs Technion-Cornell Institute | System and method for on-phase microscopy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6024983A (en) | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5284753A (en) | 1991-03-20 | 1994-02-08 | Neuro Probe, Inc. | Multiple-site chemotactic test apparatus and method |
| SE9600820D0 (sv) * | 1996-03-01 | 1996-03-01 | Pharmacia Ab | Antibodies and their use |
| US5928881A (en) * | 1996-07-11 | 1999-07-27 | Smithkline Beecham Corporation | Method of identifying agonists and antagonist for CC-CKR5 receptor |
| GB9617923D0 (en) * | 1996-08-28 | 1996-10-09 | Smithkline Beecham Plc | Novel receptor |
| US6153441A (en) * | 1998-02-17 | 2000-11-28 | Smithkline Beecham Corporation | Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof |
| US6312689B1 (en) | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
| US6649158B1 (en) * | 1998-10-15 | 2003-11-18 | Canji, Inc. | Methods and compositions to induce antitumor response |
| WO2000031261A2 (en) | 1998-11-25 | 2000-06-02 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor |
| US6329159B1 (en) | 1999-03-11 | 2001-12-11 | Millennium Pharmaceuticals, Inc. | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function |
| US6448054B1 (en) * | 1999-04-08 | 2002-09-10 | The General Hospital Corporation | Purposeful movement of human migratory cells away from an agent source |
| KR100598309B1 (ko) * | 2001-06-07 | 2006-07-10 | 케모센트릭스, 인크. | 세포 이동성 검사 |
-
2002
- 2002-05-22 KR KR1020037015768A patent/KR100598309B1/ko active IP Right Grant
- 2002-05-22 AT AT02739361T patent/ATE347695T1/de active
- 2002-05-22 EP EP02739361A patent/EP1417488B1/en not_active Expired - Lifetime
- 2002-05-22 JP JP2003504063A patent/JP4233092B2/ja not_active Expired - Lifetime
- 2002-05-22 EP EP06017100A patent/EP1717583A3/en not_active Withdrawn
- 2002-05-22 DK DK02739361T patent/DK1417488T3/da active
- 2002-05-22 WO PCT/US2002/016325 patent/WO2002101350A2/en active IP Right Grant
- 2002-05-22 US US10/154,399 patent/US7282338B2/en not_active Expired - Lifetime
- 2002-05-22 ES ES02739361T patent/ES2274041T3/es not_active Expired - Lifetime
- 2002-05-22 KR KR1020067007834A patent/KR100635703B1/ko active IP Right Grant
- 2002-05-22 DE DE60216606T patent/DE60216606T2/de not_active Expired - Lifetime
- 2002-05-22 CA CA002449628A patent/CA2449628C/en not_active Expired - Lifetime
-
2004
- 2004-11-08 HK HK04108760A patent/HK1065844A1/xx not_active IP Right Cessation
-
2005
- 2005-01-24 US US11/041,858 patent/US20050186556A1/en not_active Abandoned
-
2007
- 2007-04-17 US US11/788,334 patent/US7396653B2/en not_active Expired - Lifetime
-
2008
- 2008-06-18 JP JP2008158580A patent/JP4340713B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005518184A (ja) | 2005-06-23 |
| KR20040012888A (ko) | 2004-02-11 |
| WO2002101350A3 (en) | 2004-03-11 |
| DK1417488T3 (da) | 2007-03-05 |
| US20050186556A1 (en) | 2005-08-25 |
| ATE347695T1 (de) | 2006-12-15 |
| JP2009000113A (ja) | 2009-01-08 |
| ES2274041T3 (es) | 2007-05-16 |
| US20070196855A1 (en) | 2007-08-23 |
| EP1717583A3 (en) | 2007-10-10 |
| US7282338B2 (en) | 2007-10-16 |
| DE60216606T2 (de) | 2007-04-05 |
| KR20060054488A (ko) | 2006-05-22 |
| JP4233092B2 (ja) | 2009-03-04 |
| EP1717583A2 (en) | 2006-11-02 |
| EP1417488B1 (en) | 2006-12-06 |
| CA2449628C (en) | 2008-05-06 |
| DE60216606D1 (de) | 2007-01-18 |
| EP1417488A2 (en) | 2004-05-12 |
| JP4340713B2 (ja) | 2009-10-07 |
| KR100598309B1 (ko) | 2006-07-10 |
| EP1417488A4 (en) | 2004-07-14 |
| US7396653B2 (en) | 2008-07-08 |
| KR100635703B1 (ko) | 2006-10-17 |
| WO2002101350A2 (en) | 2002-12-19 |
| US20030017485A1 (en) | 2003-01-23 |
| CA2449628A1 (en) | 2002-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1065844A1 (en) | Cell migration assay | |
| DE60128002D1 (de) | Rezeptor-nukleinsäure und rezeptor-polypeptide | |
| ID21679A (id) | Antagonis-antagonis reseptor ccr-3 | |
| NO20001100D0 (no) | IL-8 reseptorantagonister | |
| DE60141739D1 (de) | Automatische Erkennung des Hintergrunds abgetasteter Vorlagen | |
| AU2002232518A1 (en) | Improved assay and reagents or immunological determination of analyte concentration | |
| ATE235467T1 (de) | Antagonisten des vitronectin-rezeptors | |
| DE60106607D1 (de) | Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten | |
| DK1021541T3 (da) | Aminoterminalt trunkeret MCP-2 som chemokinantagonister | |
| DE69823694T2 (de) | Thrombin-rezeptor antagonisten | |
| NO20000542L (no) | Endothelin-antagonister | |
| ATE240954T1 (de) | Oxazolidinone als 5-ht2a-antagonisten | |
| DE69838874D1 (de) | Il-8 rezeptor-antagonisten | |
| ATE418542T1 (de) | Als ccr5-antagonisten verwendbare aryloxim- piperazine | |
| GB9915034D0 (en) | Improved assay analysis | |
| ATE303370T1 (de) | Il-8 rezeptor antagonisten | |
| DE69824837D1 (de) | Il-8-rezeptor-antagonisten | |
| ATE370932T1 (de) | Ccr-3-rezeptorantagonisten vii | |
| GB2395267B (en) | Improved assay analysis | |
| EP1222210A4 (en) | IMMUNOASSAY METHOD FOR THE DETECTION OF ANTIBODIES OF A CELIAC DISEASE | |
| GB0013345D0 (en) | Modified receptor and assay | |
| DE50113995D1 (de) | Automatische Erkennung von Unternehmensnamen in sprachlichen Äusserungen | |
| ATE335995T1 (de) | Automatische klassifizierung von zellstrukturen | |
| GB9705404D0 (en) | Portable assay instrument | |
| MA26854A1 (fr) | Antagonistes recepteurs de tachykinine non-peptidique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190518 |